Disclosures for "GEMIN5 and SMN Interaction: Clue to Potential Therapeutic Targets in GEMIN5 Related Neurodevelopmental Disorder"
-
Dr. Rajan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Rajan has received research support from National Scleroderma Foundation. The institution of Dr. Rajan has received research support from Denali Therapeutics. The institution of Dr. Rajan has received research support from Abeona Therapeutics. The institution of Dr. Rajan has received research support from Regenxbio. The institution of Dr. Rajan has received research support from Shire . The institution of Dr. Rajan has received research support from Prevail Therapeutics.
-
Dr. Fortuna has nothing to disclose.
-
Dr. Kour has nothing to disclose.
-
Ms. Chimata has nothing to disclose.
-
Dr. Muiños-Bühl has nothing to disclose.
-
-
Dr. Ganesh has nothing to disclose.
-
Mr. Nelson has nothing to disclose.
-
Miss Ward has nothing to disclose.
-
Mr. O'Brien has nothing to disclose.
-
Dr. Rajasundaram has nothing to disclose.
-
The institution of Prof. Wirth has received research support from Deutsche Forschungsgemeinschaft. The institution of Prof. Wirth has received research support from European Commission.
-
Prof. Kango-Singh has nothing to disclose.
-
Udai Pandey, PhD has nothing to disclose.